The only sensing-enabled DBS system, now with the world’s first closed-loop feature for Parkinson's disease
The Percept™ family with BrainSense™ technology† is the only sensing-enabled DBS system offering insights into a patient’s condition inside and outside of the clinic throughout the patient journey.
Exclusive technology
©2025 TIME USA LLC. All rights reserved. Used under license.
may increase “On” time, on average, compared to traditional DBS (cDBS)‡
see results below from the ADAPT-PD clinical trial
hours/day§
“On” time hours
with BrainSense™ aDBS§
with good “On” time§,◊
98%
of patients with Parkinson’s disease preferred BrainSense™ aDBS over traditional DBS after using for 30 days.¶
There are risks and benefits of DBS: Risks include surgical complications, infection, failure to deliver therapy as needed and/or worsening of some symptoms.
The safety profile observed for aDBS is consistent with the safety profile for traditional DBS (cDBS). Stimulation-related side effects are expected during initial aDBS setup, such as worsening of Parkinson’s disease symptoms and dyskinesias, and are expected to resolve with reprogramming. It’s important to ensure patients have regular follow up visits to monitor response to therapy, optimize programming, and manage any stimulation-related side effects promptly, especially within aDBS adjustment and set up periods (at least within the first few months of aDBS programming). aDBS is an optional programming feature and may not work for everyone.
Access on-demand resources — videos, webinars, and more — to deepen your knowledge and uncover the innovations transforming movement disorder care.
The Percept™ PC is a recharge free neurostimulator with sensing, directionality, and advanced programming capabilities for deep brain stimulation (DBS).
Percept™ RC is a rechargeable neurostimulator with sensing, directionality, and advanced programming capabilities for deep brain stimulation (DBS).
The SenSight™ directional DBS lead system combines the benefits of directionality with the power of sensing.
Medtronic MR Conditional# systems are backed by more than 14 years of MRI research and testing history.
Access on-demand resources — videos, webinars, and more — to deepen your knowledge and uncover the innovations transforming movement disorder care.
See reimbursement codes and information for Medtronic DBS.
† The sensing feature of the Percept™ PC system and Percept™ RC system is intended for use in patients receiving DBS where chronically-recorded bioelectric data may provide useful, objective information regarding patient clinical status.
‡ Improved motor symptom control results were based on post hoc analysis averaging overall patient aDBS on time results compared to cDBS. Results presented for dual threshold aDBS. N=40. Based on results from an open-label comparison.
§ Study data with 40 patients evaluated on Dual Threshold mode.
◊ 16 hours.
¶ Clinical Summary, Data from 45 patients who were previously stable on traditional DBS (cDBS).
# Medtronic DBS systems are MR Conditional. Refer to product labeling for full list of conditions. https:manuals.medtronic.com/manuals/mri/region
